1Notarbartolo M, Cervello M, Dusonchet L, et al. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of ap
2Fukuda S, Pelus L M. Regulation of the inhibitor of apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood, 2001,98:2091-2100.
3Hoffman W H, Biade S, Zilfou J T, et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem, 2002,277:3247-3257.
4Adida C, Recher C, Raffoux E, et al. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol, 2000,111:196-203.
5Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood, 2000,96:1921-1925.
6Wall N R, Beck F W, AI-Katib A M, et al. Treatment-induced expression of anti-apoptotic proteins in WSC-CLL, a human chronic lymphocytic leukememia cell line. J Drug Target, 2001,9:329-339.
7Moriai R, Asanuma K, Kobayashi D, et al. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res, 2001,21:595-600.
8Anderson M H, Pederson L O, Becker J C, et al. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res, 2001,16:869-872.
9Kanwar J R, Shen W P, Kanwar P K, et al. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer, 2001,93:1541-1552.
10Carter B Z, Milella M, Alteiri D C, et al. Cytokine-regulated expression of survivin in myeloid leukemia. Blood, 2001,97:2784-2790.
2AMBROSINI G, ADIDA C, ALTIERI D C. A novel anti apoptosis gene,survivin,expression in cancer and lymphoma[J]. Nat Med, 1997,3 :917-921.
3DOHI T, BELTRAMI E, WALL N R, et al. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis[J]. J Clin Invest, 2004,114 : 1117 -- 1127.
4IDENOUE S, HIROHASHI Y, TORIGOE T, et al. A potent immunogenic general cancer vaccine that tar gets survivin, an inhibitor of apoptosis proteins [J]. Clin Cancer Res, 2005,11 : 1474-- 1482.
5BLANC-BRUDE O P,MESRI M,WALL N R,et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor associated angiogenesis[J]. Clin Cancer Res,2003,9:2683--2692.
6O'DRISCOLL L, I.INEHAN R, CLYNES M. Survivin: role in normal cells and in pathological conditions[J]. Curr Cancer Drug Targets, 2003,3: 131- 152.
7SUZUKI A, HAYASHIDA M, ITO T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16 and Cdk2/cyclin E complex activation [J]. Oncogene, 2000,19 : 3225 - 3234.
8Blalock W L, Weinstein-Oppenheimer C, Chang F, et al. Signal transduction, cell cycle regulatory, and antiapoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia, 1999, 13:1109-1166.
9Lisovsky M, Estrov Z, Zhang X, et al. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.Blood, 1996, 88:3987-3997.
10Carter B Z, Milella M, Altieri D C, et al. Cytokineregulated expression of survivin in myeloid leukemia.Blood, 2001, 97:2784-2790.
